7Baggers
The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.

Aptevo Therapeutics Inc
(NASDAQ:APVO) 

APVO stock logo

Aptevo Therapeutics Inc., a clinical-stage biotechnology company, focuses on developing immunotherapeutic candidates for the treatment of various forms of cancer in the United States. Its lead clinical candidate is APVO436, a bispecific T-cell engaging antibody candidate that is in Phase 1/1b clinic...

Founded: 2016
Full Time Employees: 80
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends
Aptevo Therapeutics Days Payable Outstanding ttm (DPO)
202101 202102 202103 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 0366.38732.761,099.141,465.521,831.92,198.282,564.66
Aptevo Therapeutics Op Cashflow Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -26.51-22.72-18.94-15.15-11.36-7.57-3.790
Aptevo Therapeutics Free Cashflow Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -26.51-22.72-18.94-15.15-11.36-7.57-3.790
Aptevo Therapeutics Cash Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 05.4610.9216.3721.8327.2932.7538.2
Aptevo Therapeutics P/S ratio ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -3.750.725.199.6614.1318.623.0727.54
Aptevo Therapeutics (GAAP) P/E ratio ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -0.180.210.60.991.381.772.162.55
Aptevo Therapeutics P/B ratio ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 00.140.290.430.570.720.861
No extra charts and metrics for this ticker.